Understanding neuroimmune interactions in disorders of gut–brain interaction: from functional to immune-mediated disorders
Functional gastrointestinal disorders—recently renamed into disorders of gut–brain
interaction—such as irritable bowel syndrome and functional dyspepsia are highly prevalent …
interaction—such as irritable bowel syndrome and functional dyspepsia are highly prevalent …
AGA clinical practice update on management of medically refractory gastroparesis: expert review
BE Lacy, J Tack, CP Gyawali - Clinical Gastroenterology and Hepatology, 2022 - Elsevier
Description Delayed gastric emptying on objective testing defines gastroparesis, but
symptoms overlap with functional dyspepsia and do not correlate well with gastric emptying …
symptoms overlap with functional dyspepsia and do not correlate well with gastric emptying …
British Society of Gastroenterology guidelines on the management of functional dyspepsia
Functional dyspepsia (FD) is a common disorder of gut–brain interaction, affecting
approximately 7% of individuals in the community, with most patients managed in primary …
approximately 7% of individuals in the community, with most patients managed in primary …
United European gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) consensus on gastroparesis
J Schol, L Wauters, R Dickman, V Drug… - …, 2021 - Wiley Online Library
Background Gastroparesis is a condition characterized by epigastric symptoms and delayed
gastric emptying (GE) rate in the absence of any mechanical obstruction. The condition is …
gastric emptying (GE) rate in the absence of any mechanical obstruction. The condition is …
Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial
L Wauters, H Slaets, K De Paepe… - The Lancet …, 2021 - thelancet.com
Background Current treatments for functional dyspepsia have limited efficacy or present
safety issues. We aimed to assess spore-forming probiotics in functional dyspepsia as …
safety issues. We aimed to assess spore-forming probiotics in functional dyspepsia as …
Exploring the serotonin‐probiotics‐gut health axis: A review of current evidence and potential mechanisms
N Akram, Z Faisal, R Irfan, YA Shah… - Food Science & …, 2024 - Wiley Online Library
Modulatory effects of serotonin (5‐Hydroxytryptamine [5‐HT]) have been seen in hepatic,
neurological/psychiatric, and gastrointestinal (GI) disorders. Probiotics are live …
neurological/psychiatric, and gastrointestinal (GI) disorders. Probiotics are live …
Wei-Tong-**n ameliorates functional dyspepsia via inactivating TLR4/MyD88 by regulating gut microbial structure and metabolites
X Zhang, W Liu, S Zhang, J Wang, X Yang, R Wang… - Phytomedicine, 2022 - Elsevier
Abstract Background Wei-Tong-**n (WTX) is a traditional Chinese medicine (TCM) that has
been screened and improved in accordance with the famous ancient Chinese formula" Wan …
been screened and improved in accordance with the famous ancient Chinese formula" Wan …
Nutrition and Disorders of Gut–Brain Interaction
E Scarpellini, LM Balsiger, B Broeders, KVD Houte… - Nutrients, 2024 - mdpi.com
Background: Disorders of gut–brain interaction (DGBIs) have a complex pathophysiology
that is often characterized by a relationship between food ingestion and triggering of …
that is often characterized by a relationship between food ingestion and triggering of …
Pharmacological management of gastro-esophageal reflux disease: State of the art in 2024
Introduction Gastroesophageal reflux disease (GERD) is a chronic disease of the
esophagus characterized by the regurgitation of stomach contents into the esophagus …
esophagus characterized by the regurgitation of stomach contents into the esophagus …
An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis
GJ Sanger, PLR Andrews - Alimentary Pharmacology & …, 2023 - Wiley Online Library
Background Drugs which can inhibit nausea/vomiting and/or increase gastric emptying are
used to treat gastroparesis, mostly 'off‐label'. Within each category, they act at different …
used to treat gastroparesis, mostly 'off‐label'. Within each category, they act at different …